Analysis of ALOHA (add-on Lantus® to OHA) study: Basal supported oral therapy (BOT) with insulin glargine resulted in reduction of HbA1c, FPG and PPG with nearly 2% incidence of adverse drug reactions - Kadowaki, T (World Diabetes Congress, 2011)